T. Rowe Price Associates
HLF icon

T. Rowe Price Associates’s Herbalife HLF Stock Holding History

T. Rowe Price Associates’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,600
Closed -$1.39M – 2523
2015
Q2 		$1.39M Hold
50,600
– – ﹤0.01% 1662
2015
Q1 		$1.08M Buy
+50,600
New +$864K ﹤0.01% 1710

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

T. Rowe Price Associates's HLF Position: Q1 2026 in Review

T. Rowe Price Associates increased its Herbalife (HLF) stake by 16% in Q1 2026, buying an estimated $246K and bringing the position to 111,804 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

T. Rowe Price Associates first reported a position in HLF in Q2 2013 and has held it in 52 quarters since. The position peaked at $11M in Q4 2013. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • T. Rowe Price Associates held 111,804 shares of Herbalife worth $1.65M as of Q1 2026.
  • T. Rowe Price Associates bought 15,034 Herbalife shares in Q1 2026, an estimated $246K.
  • Herbalife made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1919 holding.
  • T. Rowe Price Associates first reported a position in Herbalife in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Herbalife position peaked at $11M in Q4 2013.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.